Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00947345
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
AK6 | 4-methoxy-N-phenyl-3-({3-[(1H-pyrrolo[2,3- b]pyridin-5-ylmethyl)sulfanyl]propanoyl}amino)benzamide | A | 3DJ6 | 0.71 | |
BZC | A | 1EFY | 0.71 | ||
IID | N-(1-ISOPROPYLPIPERIDIN-4-YL)-1- (3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE | A,B | 2BQ7 | 0.71 | |
L08 | 1-ACETYL-4-(4-{4-[(2-ETHOXYPHENYL)THIO]- 3-NITROPHENYL}PYRIDIN-2-YL)PIPERAZINE | A,B,C,D | 1RD4 | 0.72 | |
PFE | {4-[3-(6,7-DIETHOXY-QUINAZOLIN- 4-YLAMINO)-PHENYL]-THIAZOL-2-YL}- METHANOL | A,F | 1KZ8 | 0.72 | |
R86 | 2-{(2R)-4-[2-(1H-IMIDAZOL-1-YL)- 6-METHYLPYRIMIDIN-4-YL]-1-ISOBUTYRYLPIPERAZIN- 2-YL}-N-[2-(4-METHOXYPHENYL)ETHYL]ACETAMIDE | A | 2ORP | 0.74 | |
EZL | 6-ethoxy-1,3-benzothiazole-2-sulfonamide | A | 3CAJ | 0.72 | |
EZL | 6-ethoxy-1,3-benzothiazole-2-sulfonamide | A | 3DCW | 0.72 | |
EZL | 6-ethoxy-1,3-benzothiazole-2-sulfonamide | A | 3DD0 | 0.72 | |
FRK | N-[4,5-BIS(4-HYDROXYPHENYL)-1,3- THIAZOL-2-YL]HEXANAMIDE | A | 1WXY | 0.74 | |
TUI | 2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL- 2-YL)UREIDO)METHYL)-1H-IMIDAZOL- 4-YL)PHENOXY)ACETIC ACID | A,B | 2Z6J | 0.72 | |
GNF | N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL- N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}- L-ALANINAMIDE | A,B | 2F1G | 0.76 | |
CK6 | 4-[4-(4-METHYL-2-METHYLAMINO-THIAZOL- 5-YL)-PYRIMIDIN-2-YLAMINO]-PHENOL | A | 1PXN | 0.71 | |
320 | 2-(4-fluorophenyl)-N-{[3-fluoro- 4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide | A | 3CTJ | 0.7 | |
039 | 2-((9H-PURIN-6-YLTHIO)METHYL)-5- CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN- 4(3H)-ONE | A | 2CHW | 0.7 | |
T2A | 5-methyl-7-phenyl-N-(3,4,5-trimethoxyphenyl)imidazo[5,1- f][1,2,4]triazin-2-amine | A,C | 3EOC | 0.71 | |
AK5 | 3-({3-[(6-amino-5-bromopyrimidin- 4-yl)sulfanyl]propanoyl}amino)- 4-methoxy-N-phenylbenzamide | A | 3DJ5 | 0.71 | |
BLZ | 5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL- 1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}- 2-THIOPHENECARBOXAMIDE | A,C | 2I40 | 0.71 | |
IZB | N-[(1S)-1-(1H-BENZIMIDAZOL-2-YL)- 2-{4-[(5S)-1,1-DIOXIDO-3-OXOISOTHIAZOLIDIN- 5-YL]PHENYL}ETHYL]-4-METHYL-3,4- DIHYDRO-2H-1,4-BENZOXAZINE-7-SULFONAMIDE | A | 2CNH | 0.72 | |
MZ6 | N-[(1S,2R)-3-{(1,3-BENZOTHIAZOL- 6-YLSULFONYL)[(2S)-2-METHYLBUTYL]AMINO}- 1-BENZYL-2-HYDROXYPROPYL]-3-HYDROXYBENZAMIDE | A,B | 2QI4 | 0.7 | |
MSQ | 4-[3-METHYLSULFANYLANILINO]-6,7- DIMETHOXYQUINAZOLINE | A | 1DI9 | 0.71 | |
608 | N-(4-phenoxyphenyl)-2-[(pyridin- 4-ylmethyl)amino]nicotinamide | A,B | 2P2I | 0.7 | |
P41 | 6-[4-(2-fluorophenyl)-1,3-oxazol- 5-yl]-N-(1-methylethyl)-1,3-benzothiazol- 2-amine | A | 3C5U | 0.74 | |
RWJ | CYCLOPENTANECARBOXYLIC ACID [1- (BENZOTHIAZOLE-2-CARBONYL)-4-GUANIDINO- BUTYL]-AMIDE | A | 1QCP | 0.71 | |
HT1 | 2'-(4-ETHOXYPHENYL)-5-(4-METHYL- 1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE | A,B | 403D | 0.7 | |
HT1 | 2'-(4-ETHOXYPHENYL)-5-(4-METHYL- 1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE | A | 129D | 0.7 | |
HT1 | 2'-(4-ETHOXYPHENYL)-5-(4-METHYL- 1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE | A,B | 130D | 0.7 | |
HT1 | 2'-(4-ETHOXYPHENYL)-5-(4-METHYL- 1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE | A | 3F8C | 0.7 | |
TFL | 2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY- 3-METHYL-1,3-BENZOTHIAZOL-3-IUM | A | 2J3Q | 0.75 | |
MZ8 | N-{(1S,2R)-3-[(1,3-BENZOTHIAZOL- 6-YLSULFONYL)(ISOBUTYL)AMINO]-1- BENZYL-2-HYDROXYPROPYL}-3-HYDROXYBENZAMIDE | A,B | 2QI6 | 0.71 | |
PR1 | 4-HYDROXY-3-[2-OXO-3-(THIENO[3,2- B]PYRIDINE-2-SULFONYLAMINO)-PYRROLIDIN- 1-YLMETHYL]-BENZAMIDINE | A | 1F0T | 0.71 | |
GW7 | N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}- 6-ethylthieno[3,2-d]pyrimidin-4- amine | A,B | 2R4B | 0.73 | |
3HT | 5-[1-(4-methoxyphenyl)-1H-benzimidazol- 6-yl]-1,3,4-oxadiazole-2(3H)-thione | A,B | 3F88 | 0.7 | |
BRL | 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2- (METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]- (9CL) | A,D,U,X | 1FM6 | 0.73 | |
BRL | 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2- (METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]- (9CL) | A,B | 2PRG | 0.73 | |
BRL | 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2- (METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]- (9CL) | A | 1ZGY | 0.73 | |
BRL | 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2- (METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]- (9CL) | A,B | 3CS8 | 0.73 | |
BRL | 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2- (METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]- (9CL) | A,D | 3DZY | 0.73 | |
COG | 2,4-DIAMINO-6-[N-(2',5'-DIMETHOXYBENZYL)- N-METHYLAMINO]QUINAZOLINE | A | 1LY3 | 0.7 | |
ID5 | [5-FLUORO-2-({[(4,5,7-TRIFLUORO- 1,3-BENZOTHIAZOL-2-YL)METHYL]AMINO}CARBONYL)PHENOXY]ACETIC ACID | A | 1T40 | 0.72 | |
ID5 | [5-FLUORO-2-({[(4,5,7-TRIFLUORO- 1,3-BENZOTHIAZOL-2-YL)METHYL]AMINO}CARBONYL)PHENOXY]ACETIC ACID | A | 1T41 | 0.72 | |
165 | N-(BENZYLSULFONYL)-3-CYCLOHEXYLALANYL- N-(2-AMINO-1,3-BENZOTHIAZOL-6-YL)PROLINAMIDE | H,I | 1SB1 | 0.72 |